A primitive hematopoietic cell is the target for the leukemic transformation in human Philadelphia-positive acute lymphoblastic leukemia

Blood

Volumn 95, Issue 3, 2000, Pages 1007-1013

  Cobaleda, C ^b   Gutierrez Cianca N ^b   Perez Losada J ^b   Flores, T ^b   Garcia Sanz R ^b   Gonzalez M ^b   Sanchez Garcia I ^a  

^a Instituto de Biología Funcional y Genómica and Departamento de Microbiología y Genética   (Spain)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL RENEWAL; CONTROLLED STUDY; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PHENOTYPE; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL;

EID: 0034141934     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v95.3.1007.003k35_1007_1013     Document Type: Article

References (37)

1. Sánchez-García I. Consequences of chromosomal abnormalities in tumour development. Ann Rev Genet. 1997;31:429-453.
2. Konopka JB, Watanabe SM, Witte ON. An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell. 1984;37:1035-1042.
3. Shtivelman E, Lifshitz B, Gale RP, Canaani E. Fused transcript of abl and bcr genes in chronic myelogenous leukemia. Nature. 1985;315:550-554.
4. Mes-Masson AM, McLaughlin J, Daley GQ, Paskind M, and Witte ON. Overlapping cDNA clones define the complete coding region from the p210c-abl gene product associated with chronic myelogenous leukemia cells containing the Philadelphia chromosome. Proc Natl Acad Sci U S A. 1986;83:9768-9772.
5. Clark SS, McLaughlin J, Crist WM, Champlin R, Witte ON. Unique forms of the abl tyrosine kinase distinguish Ph1-Positive CML from Ph1-positive ALL. Science. 1987;35:85-88.
6. Daley CG, McLaughlin J, Witte ON, Baltimore D. The CML-specific p210 bcr/abl protein, unlike v-abl, does not transform NIH/3T3 fibroblasts. Science. 1987;237:532-535.
7. Hermans A, Heisterkamp N, von Linden M, et al. Unique forms of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia. Cell. 1987;51:33-40.
8. Elelanty AG, Hariharan IK, Cory S. bcr-abl, the hallmark of chronic myeloid leukemia in man, induces multiple hemopoieitc neoplasms in mice. EMBO J. 1990;9:1069-1078.
9. Heisterkamp N, Jenster G, Hoeve HT, Zovich D, Pattengale PK, Groffen J. Acute leukemia in bcr/ abl transgenic mice. Nature. 1990;344:251-253.
10. Kelliher MA, McLaughlin J, Witte ON, Rosenberg N. Induction of chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL. Proc Natl Acad Sci U S A. 1990;87:6649-6653.
11. Gishizhy ML, Johnson-White J, Witte ON. Efficient transplantation of BCR-ABL-induced chronic myelogenous leukemia-like syndrome in mice. Proc Natl Acad Sci U S A. 1993;90:3755-3759.
12. Sánchez-García I, Grütz G. The tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL-2. Proc Natl Acad Sci U S A. 1995;92:5287-5291.
13. Fialkow PJ. Clonal evolution of human myeloid leukemias. In: Bishop JM, Rowley JD, Greaves M, eds. Genes and Cancer. New York, NY: Liss; 1984;215-223.
14. Cline MJ. Mechanisms of disease: the molecular basis of leukemia. N Engl J Med. 1994;330:328-336.
15. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood. 1995;85:1151-1168.
16. McCulloch E. Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture). Blood. 1983;62:1-13.
17. Barr FG. Translocations, cancer and the puzzle of specificity. Nature Genet. 1998;19:121-124.
18. Bennett J, et al. Proposals for the classification of the acute leukemias. Br J Haematol. 1976;33: 451-458.
19. Lapidot T, Pflumio F, Doedens M, Murdoch B, Williams DE, Dick JE. Cytokine stimulation of multilineage hematopoiesis from immature human cells engrafted in SCID mice. Science 255: 1137-1141.
20. Lowry PA, Schultz LD, Greiner DL, et al. Improved engraftment of human cord blood stem cells in NOD/LtSz-scid/scid mice after irradiation or multiple-day injections into unirradiated recipients. Biol Blood Marrow Trans. 1996;2:15-21.
21. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and non-obese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood. 1996;88:3731-3738.
22. Cashman JD, et al. Kinetic evidence of the regeneration of multilineage hematopoiesis for primitive cells in normal human bone marrow transplanted into immunodeficient mice. Blood. 1997;89:4307-4316.
23. Larochelle A, Vormoor J, Janenberg H, et al. Identification of primitive hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nature Med. 1996;2:1329-1337.
24. Bhatia M, Wang J, Kapp U, Bonnet D, Dick J. Purification of primitive human hematopoietic cells capable of repopulating NOD/SCID mice. Proc Natl Acad Sci U S A. 1997;94:5320-5325.
25. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoieitic cell. Nature Med. 1997;3:730-736.
26. Wang J, Doedens M, Dick J. Primitive human hematopoietic cells are enriched in cord blood compared to adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell (SRC) assay. Blood. 1997;89:3919-3924.
27. Traswell C. Limiting assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 1981;126:1614-1619.
28. Civin C, Strauss LC, Brovall C, et al. Antigen analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol. 1984;133:157-165.
29. Terstappen LWWM, Huang S, Safford M, Lansdorp PM, Loken MR. Sequential generations of hematopoietic colonies derived from single non-lineage-committed CD34+CD38- progenitor cells. Blood 1991;77:1218-1227.
30. Lapidot T, et al. A cell initiating human acute myeloid leukemia after transplantation into SCID mice. Nature. 1994;367:645-648.
31. Suda T, et al. A stimulatory effect of recombinant murine IL-7 on B-cell colony formation and an inhibitory effect of IL-1α. Blood 1989;74:1936-1941.
32. Choo Y, Sánchez-García I, Klug A. In vivo repression by a site-specific DNA-binding protein designed against an oncogenic sequence. Nature. 1994;372:642-645.
33. García Hernández B, Castellanos A, López A, Orfao A, Sánchez-García I. Murine hematopoietic reconstitution after tagging and selection of retrovirally transduced bone marrow cells. Proc Natl Acad Sci U S A. 1997;94:13,239-13,244.
34. Gale KB, et al. Backtracking leukemia to birth: Identification of clonotypic gene fusion sequences in neonatal blood spots. Proc Natl Acad Sci U S A. 1997;94:13,950-13,954.
35. Castellanos A, Pintado B, Weruaga E, et al. Acute leukemia in chimeric mice by a bcr-ABLp190 fusion gene made by homologous recombination. Blood. 1997;90:2168-2174.
36. Fairbairn LJ, Cowling GJ, Reipert BM, Dexter TM. Suppression of apoptosis allows differentiation and development of a multipotent haematopoietic cell line in the absence of added growth factors. Cell. 1993;4:823-833.
37. p190 cells. Mol Med. 1996;2:125-133.